Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Six Monthly Return

5 Dec 2008 14:28

RNS Number : 6401J
Ark Therapeutics Group PLC
05 December 2008
 



Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

2,536,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

5,000

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

2,531,252

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

7,750

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

992,250

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUVUSRWRRURAA
Date   Source Headline
13th Jul 200610:26 amRNSHolding(s) in Company
27th Jun 20063:34 pmRNSHolding(s) in Company
21st Jun 20067:01 amRNSRe Agreement
9th Jun 20061:58 pmRNSHolding(s) in Company
5th Jun 20063:44 pmRNSBlocklisting Interim Review
22nd May 20063:52 pmRNSDirectors' Shareholdings
19th May 20063:13 pmRNSRe Placing and Open Offer
27th Apr 20063:29 pmRNSResult of AGM
27th Apr 20067:03 amRNSPlacing and Open Offer
30th Mar 20067:01 amRNSRe Agreement
28th Mar 20063:22 pmRNSAnnual Information Update
9th Mar 20067:02 amRNSFinal Results
24th Feb 20064:44 pmRNSOption Awards
15th Feb 20067:01 amRNSRe Agreement
9th Feb 200611:18 amRNSDirector Share Dealing
19th Jan 200611:12 amRNSNotice of Results
16th Jan 20067:01 amRNSResearch Update
12th Jan 20067:00 amRNSUS Patent for Kerraboot
3rd Nov 20057:01 amRNSGrant for New Facility
28th Oct 20057:01 amRNSResearch Update
28th Oct 20057:01 amRNSRegulatory Application
28th Oct 20057:01 amRNSResearch Update
20th Oct 20057:00 amRNSArk Granted Licence
18th Oct 20057:00 amRNSResearch Update
5th Oct 20057:00 amRNSoxLDL approval
13th Sep 20054:37 pmRNSHolding(s) in Company
9th Sep 20055:00 pmRNSHolding(s) in Company
9th Sep 20053:46 pmRNSHolding(s) in Company
31st Aug 20057:01 amRNSInterim Results
24th Aug 20055:56 pmRNSHolding(s) in Company
5th Aug 20057:00 amRNSResearch Update
29th Jul 20056:00 pmRNSHolding(s) in Company
28th Jul 20053:48 pmRNSNotice of Results
25th Jul 20055:28 pmRNSInterest in Shares
21st Jul 20057:01 amRNSResearch Update
7th Jul 20057:00 amRNSBoard Appointment
23rd Jun 20058:41 amRNSDirector Shareholding
21st Jun 20057:00 amRNSResearch Update
14th Jun 20057:00 amRNSSigns Marketing Deal
8th Jun 20054:41 pmRNSListing Applications
7th Jun 20053:40 pmRNSHolding(s) in Company
19th May 20057:00 amRNSKerraboot Marketing Deal
4th May 20057:00 amRNSStrengthened Patent Position
3rd May 20056:11 pmRNSHolding(s) in Company
28th Apr 20054:25 pmRNSDoc re. Result of AGM
14th Apr 20057:00 amRNSResearch Update
7th Apr 20057:00 amRNSAppointment
1st Apr 20052:43 pmRNSNotice of AGM
1st Apr 20057:00 amRNSRe Agreement
23rd Mar 20057:00 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.